Blog Insights from the Bench

Trispecific antibodies September 10, 202612 min Read

Trispecific ADCs: Why Three Targets Can Beat Two

Most antibody-drug conjugates hit one target. Real tumors aren't that cooperative. Here's what a third arm changes, where the evidence sits ...

Bispecific Antibodies September 10, 202612 min Read

The Guide to Bispecific Antibody Platforms (2026)

Engineering a bispecific antibody lead candidate involves thousands of options within two high-level approaches. We examine the trade-offs ...

Bispecific Antibodies September 10, 202612 min Read

How Are Bispecific Antibodies Made? A Quick Look Inside the Process

Bispecific antibodies are made by preparing the target, finding strong binders, assembling them into one molecule, and then purifying and ...

Multispecific Engineering September 10, 20265 min Read

Quick Path to POC

Choosing Stage-Appropriate Purification Strategies: A Quick Path to POC

Multispecific Engineering September 10, 202610 min Read

A Crank of the Invenra Discovery Engine Produces Therapeutic Quality Antibodies

The traditional antibody discovery paradigm relies on animal immunization (WT or transgenic). It is a proven process but one with lengthy ...

Trispecific antibodies September 10, 20265 Min Read

Trispecific Antibodies: What's Possible Right Now

A trispecific antibody binds three targets at once, which opens up biology two arms can’t reach. Typical multispecific engineering ...

Bispecific Antibodies September 10, 202610 min Read

Bispecific Antibody Discovery in 2026: A Practical Guide

Bispecific antibodies engage two targets with one molecule, and how well a platform handles the underlying assembly problem decides whether ...